Upgrade to SI Premium - Free Trial

Depomed (DEPO) to Acquire U.S. Rights to Cosyntropin, Divest Lazanda in Pact with Slan

November 7, 2017 4:03 PM
Depomed Inc. (NASDAQ: DEPO) announced today that it has entered into an agreement with Slán Medicinal Holdings Limited (“Slán”) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Management Comments Mergers and Acquisitions

Next Articles